http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 SAN MATEO, CA, November 12, 2009 -- Nile Therapeutics, Inc. (NASDAQ: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced its third quarter... http://pharmalicensing.com/redirs/news_rss//public/news/view/499906/0/1/nile-therapeutics-reports-2009-third-quarter-financial-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499906/0/1/nile-therapeutics-reports-2009-third-quarter-financial-results Schlieren (Zurich), Switzerland, November 10, 2009 - Cytos Biotechnology Ltd (SIX:CYTN) today gave an update on the development of its hypertension vaccine CYT006-AngQb. In a first phase IIa study... http://pharmalicensing.com/redirs/news_rss//public/news/view/499589/0/1/cytos-biotechnology-updates-on-the-development-of-the-hypertension-vaccine-cyt006-angqb http://pharmalicensing.com/redirs/news_rss//public/news/view/499589/0/1/cytos-biotechnology-updates-on-the-development-of-the-hypertension-vaccine-cyt006-angqb IRVINE, Calif., Nov. 10 -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products used in the treatment of patients suffering from severe angina, today reported... http://pharmalicensing.com/redirs/news_rss//public/news/view/499614/0/1/cardiogenesis-reports-third-quarter-2009-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499614/0/1/cardiogenesis-reports-third-quarter-2009-results 7 November 2009 (Flagstaff, Arizona) - W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG http://pharmalicensing.com/redirs/news_rss//public/news/view/499658/0/1/gore-receives-european-ce-mark-approval-for-next-generation-conformable-gore-tag http://pharmalicensing.com/redirs/news_rss//public/news/view/499658/0/1/gore-receives-european-ce-mark-approval-for-next-generation-conformable-gore-tag PITTSBURGH, Nov. 2, 2009--Privately held CardiacAssist Inc. announced today that the Cardiovascular Institute of Stanford (University) Hospital & Clinics (Palo Alto, Calif.) is one of the newest... http://pharmalicensing.com/redirs/news_rss//public/news/view/498821/0/1/cardiacassist-expands-market-penetration-of-tandemheart http://pharmalicensing.com/redirs/news_rss//public/news/view/498821/0/1/cardiacassist-expands-market-penetration-of-tandemheart IRVINE, Calif., October 27, 2009 -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and nine months... http://pharmalicensing.com/redirs/news_rss//public/news/view/499823/0/1/endologix-reports-47-third-quarter-2009-revenue-growth http://pharmalicensing.com/redirs/news_rss//public/news/view/499823/0/1/endologix-reports-47-third-quarter-2009-revenue-growth RARITAN, N.J. (Oct. 23, 2009) - Ortho Clinical Diagnostics announced the launch of FETALSCREEN(TM) II Fetal Maternal Hemorrhage Screening Test, a simple, qualitative test that detects D (Rho)... http://pharmalicensing.com/redirs/news_rss//public/news/view/499817/0/1/ortho-clinical-diagnostics-launches-fetalscreen-tm-ii-fetal-maternal-hemorrhage-screening-test http://pharmalicensing.com/redirs/news_rss//public/news/view/499817/0/1/ortho-clinical-diagnostics-launches-fetalscreen-tm-ii-fetal-maternal-hemorrhage-screening-test October 20, 2009--W. L. Gore & Associates (Gore) today announced the first human implants of the next generation Conformable GORE TAG http://pharmalicensing.com/redirs/news_rss//public/news/view/497075/0/1/gore-announces-first-implant-of-next-generation-conformable-gore-tag http://pharmalicensing.com/redirs/news_rss//public/news/view/497075/0/1/gore-announces-first-implant-of-next-generation-conformable-gore-tag Sydney 17 June 2009: Cardiac catheter manufacturer CathRx Ltd (ASX: CXD) today announced it had commenced a human pilot trial of its first therapeutic catheter for use in both atrial flutter and... http://pharmalicensing.com/redirs/news_rss//public/news/view/498618/0/1/cathrx-announces-commencement-of-pilot-trial-for-its-irrigated-ablation-catheter http://pharmalicensing.com/redirs/news_rss//public/news/view/498618/0/1/cathrx-announces-commencement-of-pilot-trial-for-its-irrigated-ablation-catheter